AU2002366470A1 - Membrane-associated glutathione-nonspecific prostaglandin e synthase - Google Patents

Membrane-associated glutathione-nonspecific prostaglandin e synthase

Info

Publication number
AU2002366470A1
AU2002366470A1 AU2002366470A AU2002366470A AU2002366470A1 AU 2002366470 A1 AU2002366470 A1 AU 2002366470A1 AU 2002366470 A AU2002366470 A AU 2002366470A AU 2002366470 A AU2002366470 A AU 2002366470A AU 2002366470 A1 AU2002366470 A1 AU 2002366470A1
Authority
AU
Australia
Prior art keywords
prostaglandin
nonspecific
synthase
membrane
glutathione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366470A
Inventor
Katsuyuki Hashimoto
Seiji Ito
Hiroaki Ohkubo
Yoshihiro Ohmiya
Sumio Sugano
Naomi Tanikawa
Kikuko Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Publication of AU2002366470A1 publication Critical patent/AU2002366470A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2002366470A 2001-12-17 2002-12-16 Membrane-associated glutathione-nonspecific prostaglandin e synthase Abandoned AU2002366470A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001383226 2001-12-17
JP2001-383226 2001-12-17
JP2002-158597 2002-05-31
JP2002158597 2002-05-31
PCT/JP2002/013113 WO2003052103A1 (en) 2001-12-17 2002-12-16 Membrane-associated glutathione-nonspecific prostaglandin e synthase

Publications (1)

Publication Number Publication Date
AU2002366470A1 true AU2002366470A1 (en) 2003-06-30

Family

ID=26625094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366470A Abandoned AU2002366470A1 (en) 2001-12-17 2002-12-16 Membrane-associated glutathione-nonspecific prostaglandin e synthase

Country Status (3)

Country Link
JP (1) JPWO2003052103A1 (en)
AU (1) AU2002366470A1 (en)
WO (1) WO2003052103A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181303A4 (en) * 1999-04-09 2003-04-09 Human Genome Sciences Inc 50 human secreted proteins
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
WO2001022920A2 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
JP2004500816A (en) * 2000-01-14 2004-01-15 インサイト・ゲノミックス・インコーポレイテッド Drug metabolizing enzymes

Also Published As

Publication number Publication date
JPWO2003052103A1 (en) 2005-04-28
WO2003052103A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
AU2002349297A1 (en) Statin-like compounds
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2002359165A1 (en) Novel compounds
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AUPR362001A0 (en) New compound
AUPR878201A0 (en) New compounds
AU2002364244A1 (en) Waterguard tube
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002323358A1 (en) Methods for preparing purified prostaglandin e synthase
AUPR920301A0 (en) Neurologically-active compounds
AU2002366470A1 (en) Membrane-associated glutathione-nonspecific prostaglandin e synthase
AU2002346030A1 (en) Novel receptors
AU2001235990A1 (en) Prostaglandin e derivatives
WO2002077001A9 (en) Novel receptors
AU2002239029A1 (en) Prostaglandin ep1 receptor
AU2002337329A1 (en) Ascopyrone p synthase
AU2004201666B2 (en) 4-Imidazolin-2-one compounds
AU2002346861A1 (en) Substituted 1h-quinolin-2-one compounds
AU2002363108A1 (en) 4-imidazolin-2-one compounds
AU2002235881A1 (en) Compounds
AU2002337136A1 (en) Isocyanato-isocyano compounds
AU2002306300A1 (en) Azasugar compounds
AU2002333307A1 (en) Substituted propargylamines
AU2002335529A1 (en) Novel carbamoylpyrrolidone derivative

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase